On the afternoon of March 14, Xu Huimin, member of the Standing Committee of the Suzhou Municipal Party Committee and Secretary of the Suzhou Industrial Park Party Working Committee, led a team to our company for safety inspection. Ding Lixin, member of the Party Working Committee and deputy director of the management committee of the park, as well as the principals of the Science and Technology Bureau, the Planning and Construction Commission, the Comprehensive Law Enforcement Bureau (SAWS), and the Public Security Branch Bureau accompanied the inspection.
After inspecting laboratories and temporary warehouses in the field, Secretary Xu said that it is necessary to explore a special management method based on the special requirements of biomedical R & D enterprises for safe production. He said that the Dushu Lake Science and Education Innovation Zone, where Borui Pharmaceuticals is located, has high density, strong professionalism, and frequent use of flammable and explosive chemicals. Many companies integrate R & D, experiment, pilot plant and small batch production. Enterprises should effectively strengthen crisis awareness, safety supervision should further clarify their responsibilities, and urge science and education innovation zones and bio-nano parks dangerous goods warehouses to be opened in a timely manner and provide relevant supporting services.
Secretary Xu knew the safety management system of Borui Medicine in detail. After carefully examining the potential safety hazards, he gave a positive evaluation of the work of Borui Medicine in safety production. He emphasized that safe production is the basis for the orderly operation of enterprises, especially high-speed growing high-tech companies, which simply focus on the speed and efficiency of development. Ignoring safe production will bring unsustainable business risks to the company. Without safety, there will be no development. Strengthen the subject's sense of responsibility, implement the "one position, two responsibilities" system, and truly ensure the safety of production safety.
Borui's EHS department is directly under the management of the group's operating department and is responsible for the group's production safety management functions. With the development of the enterprise, the depth and breadth of the work of the EHS department has also been continuously extended, and ensuring the safety of production and operation has always been the focus of Borui Pharmaceutical's work.
Based on the 13 elements of enterprise safety production standardization and enterprise production standardization (level 3), the EHS department has implemented a safety production responsibility system and formulated safety goals and tasks. Established an enterprise safety production committee at the group level, and conducted monthly safety meetings (examination of potential safety hazards, implementation of rectification of hidden dangers, compliance evaluation of laws and regulations, and focus on subsequent safety work), and conducted emergency drills each year for emergency plans (Twice), a one-vote veto system for safety responsibility was implemented in the performance evaluation. In 2016, the company continued to invest more than 4 million yuan to meet emission standards and energy conservation and emission reduction requirements on environmentally friendly hardware, and to test tail gas emissions every quarter (to ensure the effectiveness of activated carbon adsorption devices). The Group and its subsidiaries are equipped with safety production management personnel. Safety management personnel and main persons in charge, special equipment operators and special operators have joined the post after holding safety and professional training.
With the attention of the group leaders and the active cooperation of all colleagues, the company has made some achievements in safety production: in 2013, Xintai Pharmaceutical (Suzhou) Co., Ltd. obtained the ISO14000 environmental system, and in 2015 it obtained industrial production and trade enterprises' standardization of safety production (level 3 ), Borui Pharmaceutical obtained relevant environmental protection approval in accordance with the requirements of the "three simultaneous" system.